News article
IMI2 JU - 14th Call Open to Applications
15/03/2018
Funding is available for consortia to develop new approaches and technologies for the prevention, diagnosis and treatment of diseases with high impact on public health.
The Innovative Medicines Initiative 2 Joint Undertaking (IMI2 JU) is a jointly funded partnership between the European Union, represented by the European Commission, and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The initiative seeks to involve a broader range of partners, including mid-sized companies, from different sectors, eg biomedical imaging, medical information technology, diagnostic and/or animal health industries. Involving the wider community in this way is expected help to advance the development of new approaches and technologies for the prevention, diagnosis and treatment of diseases with high impact on public health.